DEA tana ƙin za a sake gyara Marijuana
Kuna iya ɗaukar cewa marijuana ya tabbatar da cewa yana da darajar kiwon lafiya da kuma amfani da shi don dalilai na kiwon lafiya. Zai zama mai sauƙi a jawo waɗannan ƙaddara saboda yawancin jihohi sun ba da izini shan shan taba don amfani da lafiya.
Amma, gaskiyar ita ce Gwamnatin Amirka da Abinci da Drug Administration ba ta amince da taba shan marijuana ba, saboda kowace cuta ko cuta, kuma a gaskiya ma, ta yanke shawarar cewa marijuana kyafaffen yafi cutar fiye da yadda yake da kyau.
Ko da yake ana gudanar da bincike a kan amfani da magungunan da aka samo daga sinadirai a jikin marijuana, wanda ake kira cannabinoids, shan shan taba har yanzu yana da damuwa mai tsanani ga jami'an kiwon lafiya da kungiyoyin kiwon lafiya.
Haɗari ga Yara da Iyaye
Ƙungiyar Harkokin Kiyaye Harkokin Kiwon Lafiya ta Amurka ta damu da cewa cigaba da karfin motsi ta marijuana a jihohi a ko'ina cikin ƙasa tana kawo hatsari ga 'ya'yanmu, iyalan mu, da kuma al'umma kanta.
DEA ya yi imanin cewa 'yancin marijuana "za su zo ne a kan kudin da' ya'yanmu da lafiyar jama'a suke ciki," kuma cewa labarin da yake amfani da marijuana kyauta shi ne maganin da ba daidai ba ga 'ya'yan yau.
Samun Maganin Faɗar Ma'aikata
Don magance waɗannan labarun da ke kewaye da wariyar likita, DEA ta wallafa littafin ɗan littafin 30, "Rashin haɗari da Abubuwan Wutar Marijuana Abuse," wanda ke nuna dalilai cewa "kyautar marijuana ba magani bane."
Wannan rahoto ya nuna matsayin FDA a kan batun warkaswa na likita , da kuma manufofi da matsayi na wasu kungiyoyin kiwon lafiya na kasa, wadanda ke mayar da hankali kan cututtuka da kuma yanayin da ake yi wa marijuana.
Abinci da Drug Administration
Bisa ga wani "Shawarar Inter-Agency game da Da'awar cewa Smoked Marijuana Yama Magunguna ne," FDA ta ruwaito cewa "akwai hujjoji a halin yanzu cewa kyautar marijuana kyauta ne."
Maimakon amincewa da marijuana kyauta don yin amfani da lafiya, asusun FDA na shekara ta 2006 ya ce "babu wani nazarin kimiyya mai kyau wanda ke amfani da maganin shan marijuana don magani a Amurka, kuma babu wani dabba ko bayanan mutum wanda zai iya kare lafiyarta ko kuma inganci na marijuana don amfani da lafiyar likita. "
Ƙungiyar lafiya ta Amirka
A cikin watan Nuwamba 2013, Cibiyar Harkokin Kiwon Lafiyar Jama'ar Amirka ta bayar da wata "Dokar AMA game da Cannabis, H-95.998," wadda kungiyar ta ce cewa cannabis wata magungunan miyagun ƙwayoyi ne kuma saboda irin wannan ne lafiyar jama'a da kuma sayar da miyagun ƙwayoyi. ba za a halatta ba.
Maganar AMA ta ce mutane da suke amfani da marijuana ba za a tsare su ba amma suna kula da lafiyar jiki, amma ana bukatar karin bincike kafin a tabbatar da marijuana a matsayin likita.
Ƙungiyar {asar Amirka ta Harkokin Addini
A watan Yulin 2012, ASAM ta ba da sanarwar manufofin jama'a dangane da likitancin likita wanda kungiyar ta ce: "Dukkan cannabis, kayayyakin cannabis, da kuma kayan aiki na cannabis ya kamata su kasance daidai da ka'idodin da ake amfani dasu ga dukkan maganin magani da na'urorin kiwon lafiya, kuma kada a rarraba ko an ba da shi ga marasa lafiya. "
Maganar ASAM ta kuma hana "tsangwama a cikin tsari na amincewa da shan magani na tarayya" kuma ya ce kungiyar ta amince da shawarwari don halatta marijuana a Amurka.
Ƙungiyar Ciwon Kankara ta Amirka
Daya daga cikin manyan hujjoji game da yin amfani da marijuana na likita shine alamun da aka bayar na taimakawa marasa lafiya marasa lafiya da ta hanyar maganin cutar shan magani tare da jin zafi da tashin hankali, amma a cikin watan Afrilu 2010, Cibiyar Cancer na Amurka ya ba da takardar shaidar da kungiyar ta ce "ba suna yin amfani da yin amfani da marijuana ko kuma halattaccen marijuana. "
Kamfanin ACS ya ce mafi kyau kuma ana bukatar maganin jiyya sosai don shawo kan cutar ciwon daji da kuma kulawa da shi kuma kungiyar tana goyon bayan ƙarin bincike akan amfanin cannabinoids.
Kamfanin Glaucoma na Amirka
Ana amfani da amfani da marijuana a matsayin magani ga marasa lafiyar glaucoma kuma yana daya daga cikin dalilan da suka fi dacewa da cewa an rubuta marijuana a jihohi inda doka take, amma amfani da shi ba ta goyan bayan Cibiyar Glaucoma na Amurka ba.
A cikin watan Afrilu 2012, kungiyar ta wallafa wata takarda ta cewa, "kodayake marijuana na iya rage matsa lamba na intraocular, da illa da kuma gajeren lokaci na aiki, tare da rashin shaidar cewa amfani da shi ya canza tsarin glaucoma, ya hana bada shawarar wannan magani a kowane nau'i don kula da glaucoma a yanzu. "
Mahimmanci, AGS ta ce babban kashi na marijuana da ake buƙata don samar da sakamako ya fi hatsari fiye da duk wani amfani.
Cibiyar Harkokin Ilimin Harkokin Ilmin Amirka
A shekara ta 2004, AAP ta wallafa rahoto, "Magana akan Marijuana: Rashin Imfani a kan Matasa," wanda kungiyar ta ce yayin da yake goyan bayan bincike kan yiwuwar yin amfani da cutar ta cannabinoids, ya tsayayya da halattacciyar marijuana saboda "zai iya shafar amfani da amfani tsakanin matasa. "
Cibiyar Nazarin Ƙananan yara da yara
A watan Yunin 2012, AACAP ta bayar da wata sanarwa da ta ce, "Magungunan maganin marijuana kyafaffen ya gurbata tunanin da aka sani game da hadarin da aka yi amfani da ita da kuma amfani da wannan magani."
Kungiyar ta ce babbar damuwa shi ne cewa "masu amfani da marijuana a yara sun fi dacewa da masu girma don amfani da mutuncin marijuana, kuma amfani da su mai nauyi yana haɓaka da haɓakawa da yawa kuma ya kara ƙaddamar da yanayin psychotic, yanayi, da kuma rikici."
Ƙungiyar Ƙwararrun Ƙwararrun Masalatai ta kasa
A watan Janairu 2013, NMSS ta wallafa rahoto game da "Magunguna da Magunguna," in ji shi, "akwai halin yanzu ba cikakke bayanai don bayar da shawarar marijuana ko abubuwan da aka samo asali don maganin bayyanar MS."
Ƙungiyar tana tallafawa ƙarin bincike game da yiwuwar aikin marijuana a maganin MS amma a halin yanzu yana tallafa wa sauran gwada-gwaje-gwaje, masu amfani da FDA don magance su.
Ƙungiyar Ƙungiyar Ƙwararrun Makaranta
A watan Maris na 2013, NASN ta wallafa "Rajistar Marijuana, Bayanin Tattaunawa," inda kungiyar ta bayyana cewa marijuana ya dace da shi a matsayin jigon Jakadanci da kuma cewa "cikakkiyar nauyin shaidu na yanzu suna goyon bayan wannan jinsin."
Kungiyar ta nuna cewa "akwai rashin amincewa da cikakken amfani da shi don amfani da shi ko da a karkashin kula da lafiyar" don abin da ake kira marijuana.
Ƙungiyar Ƙwararrun Ƙwararrun Amurka
A cikin watan Nuwambar 2013 "Bayyana Bayanai game da Marijuana a matsayin Magunguna," APA ya ce ba wai kawai akwai hujjar kimiyya ba cewa marijuana yana da tasiri don magance duk wani cututtuka, "shaidu na yanzu suna goyon bayan, a ƙananan, ƙungiyar cannabis mai karfi amfani dasu tare da farawar cututtuka na psychiatric. "
Kamar sauran kungiyoyi a cikin wannan jerin, APA na tallafawa bincike akan ilimin likita, amma ya ce amincewa ga duk wani amfani da miyagun ƙwayoyi ya kamata ta hanyar FDA kuma "ba za a iya ba da izinin jefa kuri'a ba."
DEA tana ƙin za a sake gyara Marijuana
A watan Agustan 2016, saboda amsa tambayoyi guda biyu da za a fara shigar da matakan da za a yi na sake maye gurbin marijuana daga Jirgin I I magani a karkashin Dokar Dokar Sarrafa, DEA ta buƙaci nazarin kimiyya da likita da kuma bada shawara daga ma'aikatar lafiya da na Human Services (HHS). Cibiyar Abinci da Drugura ta Amurka (FDA) ta gudanar da gwajin a cikin shawarwari tare da Cibiyar Kasa ta Kasa ta NIDA (National Institute on Drug Abuse) (NIDA).
A sakamakon wannan gwajin, DEA ya ƙaryata game da dukiyoyi biyu don sake tsara marijuana a matsayin Jigilar I na miyagun ƙwayoyi saboda:
- Ba ya dace da ka'idoji don amfani da kiwon lafiya a halin yanzu.
- Akwai rashin amincewar da aka yi amfani dashi don yin amfani da shi a karkashin kulawar kiwon lafiya.
- Yana da babban yiwuwar zagi.
Bayanin da aka ba da shi ga masu takarda ya bayyana ainihin hujjoji da ka'idojin doka don ƙin yarda da takardun. Amsar DEA ta ce hanya mafi kyau ta tantance idan marijuana ko mambobinta suna samar da lafiyar lafiya da kuma ingantacciyar aikin likita ta hanyar binciken kimiyya ne da ke kulawa da ilimin kimiyyar da ake gudanarwa ta hanyar Dokar Abinci da Drug Administration ta US Food Process.
Babu Maganin Amfani da Wutar Marijuana
Binciken DEA na shekara ta 2016 ya tabbatar da cewa marijuana ba ya haɗu da wani abu guda biyar da ake buƙata don miyagun ƙwayoyi don yin amfani da aikin likita a yanzu:
- Dole ne a san ilmin sunadarai da kuma reproducible.
- Dole ne a sami cikakken bincike.
- Dole ne ya zama cikakkun tsari mai sarrafawa da tabbatar da inganci.
- Dole ne likitoci masu ƙwarewa su yarda da miyagun ƙwayoyi.
- Dole ne tabbatar da shaidar kimiyya ta yadu.
DEA ta gano cewa marijuana bai sadu da ɗayan ka'idodin da ke sama ba kuma babu wani daga cikin 566 da aka wallafa da aka gudanar da marijuana da ke bin ka'idodin bincike mai inganci mai kyau.
Sources:
Gwamnatin {asar Amirka ta Shirin Harkokin Kiwon Lafiya. "Ba da izinin yin takaddama don fara aiwatar da matakan da za a sake tsarawa Marijuana." Rijista Tarayya 11 Agusta 2016.
Gwamnatin {asar Amirka ta Shirin Harkokin Kiwon Lafiya. "Rashin haɗari da abubuwan da ke haifar da zalunci na Marijuana." Sakamakon Rage Halin Janairu 2014.